Oct 29, 4:34 PM ET
Quaker Chemical reported third-quarter 2026 results, with net sales of $544.5 million, up 10% from $493.8 million a year earlier, driven mainly by higher selling prices and new business wins. GAAP net income was $30.0 million, or $1.73 per diluted share, slightly below $30.5 million, or $1.75, in the prior-year quarter, while non-GAAP EPS rose to $2.39 from $2.08. Management expects fourth-quarter revenue and adjusted EBITDA to rise year over year but fall from the third-quarter level.
- Net sales were $544.5 million, up 10% year over year; selling price and product mix contributed 7 points and sales volumes 3 points.
- GAAP net income was $30.0 million, or $1.73 per diluted share, versus $30.5 million, or $1.75, in Q3 2025.
- Non-GAAP EPS was $2.39 versus $2.08; adjusted EBITDA was $89.8 million, up about 8%.
- For Q4 2026, management expects revenue and adjusted EBITDA to improve year over year but decline sequentially; it expects raw material costs to stay elevated through year-end.
Read the filing on SEC.gov ↗
Oct 22, 4:36 PM ET
Quaker Chemical appointed Neil Daniels as Vice President and Chief Accounting Officer, effective upon his anticipated start date of November 16, 2026, and he will serve as principal accounting officer. Thomas Coler, who has held that role since July 22, 2026, will step down from it and remain Executive Vice President and Chief Financial Officer.
- Neil Daniels, age 61, appointed on October 16, 2026; start date November 16, 2026
- Employment Agreement provides $370,000 annual base salary and a 2027 target incentive of 35% of base salary
- Sign-on cash bonus of $175,000, plus long-term incentive grant with an aggregate value of $110,000
- Thomas Coler ceases as principal accounting officer and continues as CFO
Read the filing on SEC.gov ↗
Oct 1, 4:36 PM ET
Quaker Chemical entered into an amendment to its credit agreement on October 1, 2026, creating a new $550 million seven-year term loan B facility. Proceeds will repay in full the U.S. Term Loans outstanding under the existing agreement, and the company said the deal extends its debt maturity profile and reduces required annual debt payments.
- $550 million term loan B facility matures October 1, 2033
- Interest at Term SOFR plus 1.750% for Term SOFR loans; quarterly amortization of 0.25% of initial principal
- Proceeds repay in full the U.S. Term Loans; their aggregate principal balance is $0 as of the amendment's effective date
- Facility is secured by first priority liens on substantially all assets and carries a 1.00% prepayment premium for a repricing event within six months
Read the filing on SEC.gov ↗
Sep 8, 4:34 PM ET
Quaker Chemical said Executive Vice President, Global Specialty and Chief Growth Officer Jeewat Bijlani will no longer serve in that role effective September 30, 2026. The company said the departure is not related to any disagreement and is treated as a termination without cause under his employment agreement, with severance subject to a customary release of claims.
- Jeewat Bijlani's departure as Executive Vice President, Global Specialty and Chief Growth Officer is effective September 30, 2026
- The company says the departure is not related to any disagreement with Bijlani
- Separation is a termination without cause; severance is subject to a customary release of claims and follows the Company's March 31, 2026 proxy statement terms
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
